HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Jiangsu Hengrui Medicine H Share Listing (PHIP Updates) - Some Points Worth the Attention

China Healthcare Weekly (May11)-Trump's Executive Order, Pharmacy's Risks, BeiGene 25Q1 Result Is Ok

Pre-IPO Green Tea Group - Thoughts on IPO Pricing and Valuation Outlook

Pre-IPO Green Tea Group (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Auntea Jenny (Shanghai) Industrial (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Fujian Lemo IoT Technology - The Outlook for Growth and Profit Margins Is Not Optimistic

Equity Capital Markets

<ul>
<li>Kayou’s business model revolves around IP licensing+blind box+multi-category expansion.With trading cards as the core traffic entry point, Kayou expands to other products, forming a synergistic effect of "card revenue+derivative products".</li>
<li>Kayou mainly relies on licensed IPs to drive growth, Its revenue are highly concentrated on limited number of IPs. The expiration of IP license agreements is “The Sword of Damocles”</li>
<li>Valuation could be lower than peers as the core risks are concentrated on IP renewal and the government's supervision of minors, which would negatively affect the sustainability of future growth.</li>
</ul>


Kayou’s business model revolves around IP licensing+blind box+multi-category expansion.With trading cards as the core traffic entry point, Kayou expands to other products, forming a synergistic effect of "card revenue+derivative products".
Kayou mainly relies on licensed IPs to drive growth, Its revenue are highly concentrated on limited number of IPs. The expiration of IP license agreements is “The Sword of Damocles”
Valuation could be lower than peers as the core risks are concentrated on IP renewal and the government's supervision of minors, which would negatively affect the sustainability of future growth.


Pre-IPO Kayou - The Strength of Business Model and the Potential Risks Behind